| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Ensysce Biosciences, Inc.'s insiders have accumulated 400,000 shares worth roughly $198K on balance.
Classified under Biotechnology (Health Care sector), ENSC's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 916.7K | $453.8K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 7, 2026 | Gower Bob G | Director | Buy | 908,614 | $0.49 | $444,169.18 | +11,182% | - | - | |
| Mar 2, 2023 | Gower Bob G | Director | Buy | 90,287 | $0.49 | $44,087.14 | +8.0% | -62.7% | -85.5% | |
| Mar 1, 2023 | Gower Bob G | Director | Buy | 379,300 | $0.48 | $182,350.19 | +50.4% | -59.0% | -83.8% | |
| Dec 9, 2022 | Gower Bob G | Director | Buy | 357,143 | $1.40 | $500,000.20 | +90.2% | -50.4% | -92.4% | |
| May 26, 2022 | Kirkpatrick Lynn | Chief Executive Officer | Buy | 97,000 | $0.50 | $48,298.50 | +34.1% | -13.6% | -98.1% | |
| Jun 19, 2020 | Morgan Stanley | 10% Owner | Sell | 776,290 | $0.00 | - | -100% | - | - | |
| Dec 1, 2017 | Hg Vora Capital Management, LLC | 10% Owner | Buy | 1,000,000 | $10.00 | $10,000,000.00 | +35.2% | - | - |